Literature DB >> 33771904

COMPARISON OF THE EFFECT OF THREE DIFFERENT DIETARY MODIFICATIONS ON MYOCARDIAL SUPPRESSION IN 18F-FDG PET/CT EVALUATION OF PATIENTS FOR SUSPECTED CARDIAC SARCOIDOSIS.

Can Ozutemiz1, Yasemin Koksel1, Jerry W Froelich1, Nathan Rubin2, Maneesh Bhargava1, Henri Roukuz1, Rebecca Cogswell1, Jeremy Markowitz1, David M Perlman1, Daniel Steinberger1.   

Abstract

Rationale: A definitive dietary preparation recommendation is not possible based on literature in achievement of myocardial suppression for diagnosis of cardiac sarcoidosis (CS) with 18F-FDG PET/CT. Our goal is to compare three different dietary preparations in achievement of the best myocardial suppression and CS diagnosis.
Methods: We retrospectively reviewed and compared three dietary preparations used at our institution. Three different diets were applied from 03/2014 to 12/2019. 24-h ketogenic diet with overnight fasting (n = 94); 18h-fasting (n = 44); 72-h daytime ketogenic diet with 3-day overnight fasting (n = 98). The interpretation of initial reports was recorded, and an independent radiologist (observer) retrospectively re-evaluated each case regarding CS diagnosis (Negative, Positive, Indeterminant) and myocardial suppression (Complete, Failed, Partial). Interobserver agreement was analyzed. We measured MaxSUV from bloodpool, liver, and the most suppressed normal myocardium.
Results: We identified superior myocardial suppression with the 72-h preparation indicated by a higher bloodpool/myocardium and liver/myocardium ratios (P<0.001). Myocardial suppression rates for 72-h ketogenic diet, 24-h ketogenic diet and 18-h fasting preparations are as follows; Complete myocardial suppression: 96.9%/68.1%/52.3%, Failed myocardial suppression: 0%/23.4%/25%, Partial myocardial suppression: 3.1%/8.5%/22.7%) (P<0.001). The 72-hour preparation had significantly fewer "indeterminant" and "positive" exams. CS diagnosis rates for 72-h ketogenic diet, 24-h ketogenic diet and 18-h fasting preparations are as follows; Negative: 82.7%/52.1%/27.3%, Indeterminant: 2.0%/24.5%/40.9%, Positive: 15.3%/23.4%/31.8% (P<0.001). High agreement was present with the observer and the report (κ=0.88)
Conclusion: A 72-h daytime ketogenic diet with 3-day overnight fasting, achieved substantially superior myocardial suppression versus 24-h ketogenic diet with overnight fasting and 18h-fasting using 18F-FDG PET/CT. This 72-h preparation results in significantly fewer "indeterminant" and potentially "false positive" CS results.
Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  Cardiac sarcoidosis; Cardiology (basic/technical); Cardiology (clinical); Fasting; Ketogenic diet; Myocardial suppression; PET/CT

Year:  2021        PMID: 33771904      PMCID: PMC8612186          DOI: 10.2967/jnumed.121.261981

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   11.082


  19 in total

Review 1.  Cardiac Sarcoidosis.

Authors:  Pranav Mankad; Brian Mitchell; David Birnie; Jordana Kron
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

2.  Prognostic Impact of FDG-PET/CT Images in Patients With Suspected Cardiac Sarcoidosis: Optimal Patient Preparation, Not Complex Unconventional Analytics, Is Key to Meaningful Data.

Authors:  Yang Lu; Nadera J Sweiss; Homer A Macapinlac
Journal:  JACC Cardiovasc Imaging       Date:  2019-01

3.  Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.

Authors:  Michael T Osborne; Edward A Hulten; Venkatesh L Murthy; Hicham Skali; Viviany R Taqueti; Sharmila Dorbala; Marcelo F DiCarli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2016-06-08       Impact factor: 5.952

4.  Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.

Authors:  Yang Lu; Christopher Grant; Karen Xie; Nadera J Sweiss
Journal:  Clin Nucl Med       Date:  2017-02       Impact factor: 7.794

5.  Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.

Authors:  Adrien Lebasnier; Damien Legallois; Boris Bienvenu; Emmanuel Bergot; Cédric Desmonts; Gérard Zalcman; Denis Agostini; Alain Manrique
Journal:  Ann Nucl Med       Date:  2018-03-20       Impact factor: 2.668

6.  Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.

Authors:  B Sgard; P-Y Brillet; D Bouvry; S Djelbani; H Nunes; C Meune; D Valeyre; M Soussan
Journal:  Clin Radiol       Date:  2018-10-25       Impact factor: 2.350

7.  Variances of dietary preparation for suppression of physiological 18F-FDG myocardial uptake in the presence of cardiac sarcoidosis: A systematic review.

Authors:  Vanessa Atterton-Evans; James Turner; Angela Vivanti; Tayla Robertson
Journal:  J Nucl Cardiol       Date:  2018-08-07       Impact factor: 5.952

8.  Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.

Authors:  Michael Soussan; Pierre-Yves Brillet; Hilario Nunes; Gabriel Pop; Matthieu-John Ouvrier; Nicolas Naggara; Dominique Valeyre; Pierre Weinmann
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

9.  A 1-week extension of a ketogenic diet provides a further decrease in myocardial 18F-FDG uptake and a high detectability of myocarditis with FDG-PET.

Authors:  Alexandra Clément; Henri Boutley; Sylvain Poussier; Julien Pierson; Mickael Lhuillier; Allan Kolodziej; Jean-Luc Olivier; Gilles Karcher; Pierre-Yves Marie; Fatiha Maskali
Journal:  J Nucl Cardiol       Date:  2018-08-20       Impact factor: 5.952

10.  Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial.

Authors:  Victor Y Cheng; Piotr J Slomka; Marie Ahlen; Louise E J Thomson; Alan D Waxman; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2009-12-15       Impact factor: 5.952

View more
  1 in total

Review 1.  The role of PET in the management of sarcoidosis.

Authors:  Robert J Vender; Hamad Aldahham; Rohit Gupta
Journal:  Curr Opin Pulm Med       Date:  2022-07-16       Impact factor: 2.868

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.